Table 4.
Top 10 co-cited references with the highest centrality on insulin resistance and ischemic cerebrovascular disease.
| Rank | Co-cited reference | Impact Factor | Centrality | Frequency |
|---|---|---|---|---|
| 1 | Rundek T, 2010, ARCH NEUROL-CHICAGO, V67, P1195, doi: 10.1001/archneurol.2010.235 | 0.53 | 14 | |
| 2 | Wang YY, 2011, AM J PHYSIOL-ENDOC M, V300, P0, doi: 10.1152/ajpendo.00301.2010 | 4.310 | 0.5 | 6 |
| 3 | Kernan WN, 2016, NEW ENGL J MED, V374, P1321, doi: 10.1056/NEJMoa1506930 | 91.245 | 0.42 | 60 |
| 4 | Nissen SE, 2007, NEW ENGL J MED, V356, P2457, doi: 10.1056/NEJMoa072761 | 91.245 | 0.34 | 7 |
| 5 | Dormandy JA, 2005, LANCET, V366, P1279, doi: 10.1016/S0140-6736(05)67528-9 | 79.321 | 0.29 | 10 |
| 6 | Boden-Albala B, 2008, STROKE, V39,P30, doi: 10.1161/STROKEAHA.107.496588 | 9.910 | 0.19 | 8 |
| 7 | Haffner SM, 1998, NEW ENGL J MED, V339, P229, doi: 10.1056/NEJM199807233390404 | 91.245 | 0.16 | 13 |
| 8 | Bonora E, 2003, DIABETES CARE, V26, P1251, doi: 10.2337/diacare.26.4.1251 | 19.112 | 0.16 | 8 |
| 9 | Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, doi: 10.1001/jama.285.19.2486 | 56.272 | 0.15 | 28 |
| 10 | Jing J, 2017, STROKE, V48, P887, doi: 10.1161/STROKEAHA.116.015613 | 9.910 | 0.13 | 26 |